We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
(+11%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.61M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.1M |
| 3 |
Axsome Therapeutics
AXSM
|
+$2.73M |
| 4 |
Pfizer
PFE
|
+$2.64M |
| 5 |
TRML
Tourmaline Bio
TRML
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
+$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Broadridge
BR
$17.2B
| $201K | 0.12% |
980
-89
| -8% | -$17.9K |
|
127
Roper Technologies
ROP
$36.3B
| $196K | 0.12% |
349
-32
| -8% | -$17.5K |
|
128
CME Group
CME
$92.2B
| $195K | 0.12% |
905
-62
| -6% | -$13K |
|
129
Arthur J. Gallagher & Co
AJG
$63.7B
| $194K | 0.12% |
777
-72
| -8% | -$17.3K |
|
130
JPMorgan Chase
JPM
$939B
| $194K | 0.12% |
969
-127
| -12% | -$22.9K |
|
131
Cboe Global Markets
CBOE
$29.8B
| $193K | 0.12% |
+1,049
| New | +$194K |
|
132
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
| $187K | 0.11% |
4,430
+48
| +1% | +$1.96K |
|
133
Immatics
IMTX
$1.24B
| $184K | 0.11% |
+17,500
| New | +$204K |
|
134
Royal Caribbean
RCL
$78.7B
| $181K | 0.11% |
1,299
-175
| -12% | -$21.9K |
|
135
Vanguard Real Estate ETF
VNQ
$39.9B
| $180K | 0.11% |
2,083
-110
| -5% | -$9.4K |
|
136
Monster Beverage
MNST
$91.4B
| $178K | 0.11% |
3,010
-285
| -9% | -$16.4K |
|
137
McDonald's
MCD
$188B
| $175K | 0.11% |
619
-55
| -8% | -$16K |
|
138
Lamb Weston
LW
$6.82B
| $170K | 0.1% |
1,600
-145
| -8% | -$15.1K |
|
139
Mondelez International
MDLZ
$77.7B
| $163K | 0.1% |
2,335
-207
| -8% | -$15.1K |
|
140
American Airlines Group
AAL
$9.58B
| $160K | 0.1% |
10,404
-1,415
| -12% | -$20.5K |
|
141
Norwegian Cruise Line
NCLH
$8.89B
| $153K | 0.09% |
7,310
-989
| -12% | -$18K |
|
142
J.M. Smucker
SJM
$12.6B
| $151K | 0.09% |
1,196
-102
| -8% | -$12.9K |
|
143
DraftKings
DKNG
$11.4B
| $148K | 0.09% |
3,254
-440
| -12% | -$17.9K |
|
144
Carnival Corporation Ltd
CCL
$36.1B
| $145K | 0.09% |
8,856
-1,198
| -12% | -$19.5K |
|
145
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
| $138K | 0.08% |
3,521
-544
| -13% | -$19.2K |
|
|
PR
146
Permian Resources
PR
$17.9B
| $132K | 0.08% |
7,485
-1,012
| -12% | -$14.8K |
|
147
iShares MSCI Mexico ETF
EWW
$1.89B
| $131K | 0.08% |
1,897
-71
| -4% | -$4.72K |
|
148
Hershey
HSY
$35.4B
| $131K | 0.08% |
672
-59
| -8% | -$11.4K |
|
149
Lennar Class A
LEN
$20.4B
| $130K | 0.08% |
782
-104
| -12% | -$15.6K |
|
150
iShares MSCI Taiwan ETF
EWT
$10B
| $130K | 0.08% |
2,671
+115
| +4% | +$5.31K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.
- AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
- AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
- AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
- AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
- AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
- AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.
Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.